Medacta Group (BATS-CHIXE:MOVEZ) - Stock Price, News & Analysis

MOVEZ Stock Overview

Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Europe, North America, the Asia-Pacific, and internationally.

About the company

MOVEZ fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	5/6
Past Performance	2/6
Financial Health	5/6
Dividends	0/6

Rewards

Trading at 19% below our estimate of its fair value

Earnings are forecast to grow 21.8% per year

Earnings have grown 14% per year over the past 5 years

Analysts in good agreement that stock price will rise by 28.3%

Risk Analysis

Has a high level of debt

Medacta Group SA Competitors

Smith & Nephew

LSE:SN.

UK£8.5b

EKF Diagnostics Holdings

AIM:EKF

UK£139.3m

ConvaTec Group

LSE:CTEC

UK£5.0b

EMIS Group

AIM:EMIS

UK£1.2b

Price History & Performance

Summary of all time highs, changes and price drops for Medacta Group
Historical stock prices
Current Share Price	CHF111.80
52 Week High	CHF134.40
52 Week Low	CHF98.40
Beta	1.15
1 Month Change	-6.13%
3 Month Change	-11.83%
1 Year Change	-8.06%
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-6.83%

Recent updates

Shareholder Returns

	MOVEZ	GB Medical Equipment	GB Market
7D	2.9%	-5.5%	1.1%
1Y	-8.1%	-13.5%	1.9%

Return vs Industry: MOVEZ exceeded the UK Medical Equipment industry which returned -13.9% over the past year.

Return vs Market: MOVEZ underperformed the UK Market which returned 2.3% over the past year.

Price Volatility

Is MOVEZ's price volatile compared to industry and market?
MOVEZ volatility
MOVEZ Average Weekly Movement	2.9%
Medical Equipment Industry Average Movement	6.6%
Market Average Movement	4.8%
10% most volatile stocks in GB Market	11.5%
10% least volatile stocks in GB Market	2.7%

Stable Share Price: MOVEZ has not had significant price volatility in the past 3 months.

Volatility Over Time: MOVEZ's weekly volatility (3%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1958	1,696	Francesco Siccardi	www.medacta.com

Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Europe, North America, the Asia-Pacific, and internationally. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine procedures. Medacta Group SA was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.

Medacta Group SA Fundamentals Summary

How do Medacta Group's earnings and revenue compare to its market cap?
MOVEZ fundamental statistics
Market cap	CHF2.22b
Earnings (TTM)	CHF46.54m
Revenue (TTM)	CHF501.95m

47.7x

P/E Ratio

4.4x

P/S Ratio

Is MOVEZ overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MOVEZ income statement (TTM)
Revenue	€510.78m
Cost of Revenue	€162.93m
Gross Profit	€347.85m
Other Expenses	€300.49m
Earnings	€47.36m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Jul 26, 2024

Earnings per share (EPS)	2.38
Gross Margin	68.10%
Net Profit Margin	9.27%
Debt/Equity Ratio	49.4%

How did MOVEZ perform over the long term?

See historical performance and comparison

Dividends

0.5%

Current Dividend Yield

25%

Payout Ratio

Does MOVEZ pay a reliable dividends?

See MOVEZ dividend history and benchmarks

When do you need to buy MOVEZ by to receive an upcoming dividend?
Medacta Group dividend dates
Ex Dividend Date	May 10 2024
Dividend Pay Date	May 14 2024
Days until Ex dividend	7 days
Days until Dividend pay date	11 days